| Systematic (IUPAC) name | |
|---|---|
| (5α)-6,17-dimethyl- 6,7-didehydro- 4,5-epoxymorphinan- 3-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Schedule I (US) |
| Identifiers | |
| CAS number | 16008-36-9 |
| ATC code | None |
| PubChem | CID 5362518 |
| UNII | Y460N7W76B |
| Synonyms | 3-Hydroxy-6,N-dimethyl- 4,5-epoxymorphin-6-en |
| Chemical data | |
| Formula | C18H21NO2 |
| Mol. mass | 283.36 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Methyldesorphine is an opioid analgesic. First synthesized in Germany in 1940 and patented in the USA in 1952,[1] it has a high potential for abuse as with any potent opioid agonist, and is sometimes found along with desomorphine as a component of the home-made opioid mixture known as "Krokodil" used in Russia and the neighboring former Soviet republics.[2] It is approximately 15 times more potent than morphine as an analgesic[3][4] but if the 6-7 bond is saturated, the β isomer is some 50 times more potent than morphine.
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)